scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1460-9568.1997.TB00750.X |
P698 | PubMed publication ID | 9383206 |
P50 | author | Kjell Fuxe | Q5747854 |
Luca Ferraro | Q38548471 | ||
William T O'Connor | Q39765198 | ||
Sergio Tanganelli | Q40454146 | ||
Tiziana Antonelli | Q42804912 | ||
P2860 | cites work | Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor | Q24563882 |
Functional architecture of basal ganglia circuits: neural substrates of parallel processing | Q29618729 | ||
Distribution of neurotensin receptors in mammalian brain. What it is telling us about its interactions with other neurotransmitter systems | Q35273394 | ||
Neurotensin, antipsychotic drugs, and schizophrenia. Basic and clinical studies | Q35273406 | ||
Intramembrane interactions between neurotensin receptors and dopamine D2 receptors as a major mechanism for the neuroleptic-like action of neurotensin | Q35273456 | ||
The neostriatal mosaic: multiple levels of compartmental organization | Q35318347 | ||
Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum | Q37067348 | ||
Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA). | Q39899202 | ||
The neurotensin receptor: is there more than one subtype? | Q41097997 | ||
Stimulation of GABA release from the rat neostriatum and globus pallidus in vivo by corticotropin-releasing factor | Q42499962 | ||
The non-peptide neurotensin receptor antagonist SR48692 is not a potent antagonist of neurotensin(8-13) responses of rat substantia nigra neurones in vitro | Q48122194 | ||
SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission | Q48146775 | ||
Possible neuronal mechanisms involved in neurotensin-induced catalepsy in mice | Q48257933 | ||
Neuromedin N is a potent modulator of dopamine D2 receptor agonist binding in rat neostriatal membranes | Q48267852 | ||
Interactions between neurotensin and dopamine in the brain: An overview | Q48750625 | ||
Neurotensin modulates autoreceptor mediated dopamine effects on midbrain dopamine cell activity | Q48769011 | ||
The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors | Q48951812 | ||
Neurotensin receptors are located on dopamine-containing neurones in rat midbrain | Q49134437 | ||
Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross-validation using in vivo voltammetry and microdialysis | Q49158261 | ||
Neurotensin counteracts apomorphine-induced inhibition of dopamine release as studied by microdialysis in rat neostriatum. | Q51746020 | ||
Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop | Q56093340 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dopamine | Q170304 |
striatum | Q1319792 | ||
P304 | page(s) | 1838-1846 | |
P577 | publication date | 1997-09-01 | |
P1433 | published in | European Journal of Neuroscience | Q5412733 |
P1476 | title | Differential effects of intrastriatal neurotensin(1-13) and neurotensin(8-13) on striatal dopamine and pallidal GABA release. A dual-probe microdialysis study in the awake rat. | |
P478 | volume | 9 |
Q43514396 | Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice |
Q64864688 | Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors. |
Q73930962 | Comparative effects of neurotensin, neurotensin(8-13) and [D-Tyr(11)]neurotensin applied into the ventral tegmental area on extracellular dopamine in the rat prefrontal cortex and nucleus accumbens |
Q43919961 | Differential effects of acute and short-term lithium administration on dialysate glutamate and GABA levels in the frontal cortex of the conscious rat. |
Q43645441 | Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist. |
Q31841102 | Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating. |
Q34503542 | Ethanol-induced alterations of amino acids measured by in vivo microdialysis in rats: a meta-analysis |
Q48323311 | Functional neuroanatomy of the basal ganglia as studied by dual-probe microdialysis |
Q43698345 | Functional neuroanatomy of the ventral striopallidal GABA pathway. New sites of intervention in the treatment of schizophrenia |
Q46691563 | Heightened amygdala long-term potentiation in neurotensin receptor type-1 knockout mice |
Q33751029 | Molecular and anatomical signatures of sleep deprivation in the mouse brain |
Q28581544 | Neurotensin activates GABAergic interneurons in the prefrontal cortex |
Q46704914 | Neurotensin enhances GABAergic activity in rat hippocampus CA1 region by modulating L-type calcium channels |
Q37168720 | Neurotensin in the ventral pallidum increases extracellular gamma-aminobutyric acid and differentially affects cue- and cocaine-primed reinstatement |
Q62965080 | Neurotensin increases endogenous glutamate release in rat cortical slices |
Q42489739 | Neurotensin regulates cortical glutamate transmission by modulating N-methyl-D-aspartate receptor functional activity: an in vivo microdialysis study |
Q34205082 | Neurotensin: dual roles in psychostimulant and antipsychotic drug responses |
Q30301288 | Neurotensinergic Excitation of Dentate Gyrus Granule Cells via Gαq-Coupled Inhibition of TASK-3 Channels |
Q42488644 | Possible mechanisms of the involvement of dopaminergic cells and cholinergic interneurons in the striatum in the conditioned-reflex selection of motor activity |
Q43960792 | Presynaptic action of neurotensin on cultured ventral tegmental area dopaminergic neurones |
Q33493599 | Presynaptic action of neurotensin on dopamine release through inhibition of D(2) receptor function |
Q36597380 | Receptor-receptor interactions as studied with microdialysis. Focus on NTR/D2 interactions in the basal ganglia |
Q28582782 | Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat |
Q36544566 | The role of neurotensin in central nervous system pathophysiology: what is the evidence? |
Q48407590 | The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop. |
Search more.